Jeffrey D Hasday

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Signaling Pathway

Inflammatory Response

Molecular Dynamics Simulations

Top Venues

The Journal of biological chemistry

The Journal of pharmacology and experimental therapeutics

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, Wendy Luo, Ritu Lal, Adam Galan, Omar Mahmoud, Nathaniel McClean, Kiruphagaran Thangaraju, Daniel Cericola, Daniel Lewis, William A Murphy, Steven Fletcher, Alexander D MacKerell, Stefanie N Vogel, Paul Shapiro, Jeffrey D Hasday
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties. The Journal of pharmacology and experimental therapeutics (2024)
Rachel G Scheraga, Susamma Abraham, Lisa M Grove, Brian D Southern, James F Crish, Apostolos Perelas, Christine McDonald, Kewal Asosingh, Jeffrey D Hasday, Mitchell A Olman
TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching. Journal of immunology (Baltimore, Md. : 1950) 204 (5) (2020)
Daniel J Deredge, Patrick L Wintrode, Mohan E Tulapurkar, Ashish Nagarsekar, Yinghua Zhang, David J Weber, Paul Shapiro, Jeffrey D Hasday
A temperature-dependent conformational shift in p38α MAPK substrate-binding region associated with changes in substrate phosphorylation profile. The Journal of biological chemistry 294 (34) (2019)